{"transactions":[{"id":4629977,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32183,"kind":"person","name":"Beltran Pedro","position":1,"cik":"0002058152","reported_name":"Beltran Pedro","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-05T20:12:46.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1047,"price":3.94,"value":4125.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":43529,"source":{"system":"sec-edgar","filing":"0001193125-26-414127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058152/000119312526414127/ownership.xml","form_type":"4"}},{"id":715545,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32183,"kind":"person","name":"Beltran Pedro","position":1,"cik":"0002058152","reported_name":"Beltran Pedro","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-06T22:00:03.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1047,"price":7.8,"value":8166.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":44576,"source":{"system":"sec-edgar","filing":"0001193125-26-296501","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526296501/ownership.xml","form_type":"4"}},{"id":782678,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32183,"kind":"person","name":"Beltran Pedro","position":1,"cik":"0002058152","reported_name":"Beltran Pedro","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T20:11:42.000Z","date":"2026-05-10","kind":"grant","planned":false,"acquired":true,"shares":1103837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 20, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":1103837,"derivative":{"exercise_price":7.66,"expiration_date":"2036-05-09","underlying":"Common Stock","underlying_shares":1103837},"source":{"system":"sec-edgar","filing":"0001193125-26-219439","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526219439/ownership.xml","form_type":"4"}},{"id":791911,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32183,"kind":"person","name":"Beltran Pedro","position":1,"cik":"0002058152","reported_name":"Beltran Pedro","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-05T23:03:26.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1047,"price":9.03,"value":9454.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":45623,"source":{"system":"sec-edgar","filing":"0001193125-26-207035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526207035/ownership.xml","form_type":"4"}},{"id":846409,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32183,"kind":"person","name":"Beltran Pedro","position":1,"cik":"0002058152","reported_name":"Beltran Pedro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-12T20:57:30.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":210000,"derivative":{"exercise_price":10.19,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001193125-26-104379","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526104379/ownership.xml","form_type":"4"}},{"id":846408,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32183,"kind":"person","name":"Beltran Pedro","position":1,"cik":"0002058152","reported_name":"Beltran Pedro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:57:30.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":46670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments over a period of four years from January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. The RSUs will be settled in shares of Common Stock upon vesting."}],"balance_after":46670,"source":{"system":"sec-edgar","filing":"0001193125-26-104379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526104379/ownership.xml","form_type":"4"}},{"id":1053713,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32183,"kind":"person","name":"Beltran Pedro","position":1,"cik":"0002058152","reported_name":"Beltran Pedro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-28T20:39:42.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":357177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A fraction of the shares underlying such option equal to (x) the number of full months between August 11, 2025 (\"Vesting Commencement Date\") and the date on which a registration statement on Form S-8 is filed and effective with the Securities and Exchange Commission (the \"S-8 Filing Date\") divided by (y) 48 shall vest on the S-8 Filing Date, and 1/48th of the shares underlying such option shall vest each month thereafter on the day of the month corresponding to the Vesting Commencement Date (and if there is no suchcorresponding day for a month, then the vesting date shall be the last day of the applicable month) until 100% of the shares underlying such option is vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service the Issuer on each such vesting date."}],"balance_after":357177,"derivative":{"exercise_price":9.59,"expiration_date":"2035-08-25","underlying":"Common Stock","underlying_shares":357177},"source":{"system":"sec-edgar","filing":"0000950170-25-112003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000095017025112003/ownership.xml","form_type":"4"}}]}